A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : FI / formalin-inactivated

[Related PubMed/MEDLINE]
Total Number of Papers: 22
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   FI  (>> Co-occurring Abbreviation)
Long Form:   formalin-inactivated
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 CD4+ T Cells Drive Lung Disease Enhancement Induced by Immunization with Suboptimal Doses of Respiratory Syncytial Virus Fusion Protein in the Mouse Model. ERD, RSV
2017 Immunization with Low Doses of Recombinant Postfusion or Prefusion Respiratory Syncytial Virus F Primes for Vaccine-Enhanced Disease in the Cotton Rat Model Independently of the Presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) Adjuvant. ERD, GLA, post-F, pre-F, RSV, SE
2017 In Vitro Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in Infants. ADE, ADE, matAbs, RSV
2015 Review of enterovirus 71 vaccines. EV71, HFMD
2014 Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease. Ip
2012 Production of EV71 vaccine candidates. CV, EV71, HFMD
2012 Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model. IL-4, RSV
2010 Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies. BRSV, IL-5, ODN, PP
2008 Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. HP, LP, NL219
10  2007 CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease. RSV
11  2007 Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease. RSV
12  2006 Kinetics of antiviral CD8 T cell responses during primary and post-vaccination secondary bovine respiratory syncytial virus infection. BRSV
13  2005 Formalin-inactivated bovine RSV vaccine influences antibody levels in bronchoalveolar lavage fluid and disease outcome in experimentally infected calves. BALF, BRSV, RSV
14  2004 Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge. CMI, CTL, IFN-gamma, IL-2, LDL, PBMC, RSV, RT-PCR
15  2003 Antibody-dependent enhancement, a possible mechanism in augmented pulmonary disease of respiratory syncytial virus in the Bonnet monkey model. RSV
16  2003 Clinical experience with respiratory syncytial virus vaccines. PFP, RSV
17  2003 Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: exploring the parameters of pathogenesis. BRSV, HRSV
18  2001 Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine. RSV
19  1997 Priming with live respiratory syncytial virus (RSV) prevents the enhanced pulmonary inflammatory response seen after RSV challenge in BALB/c mice immunized with formalin-inactivated RSV. RSV
20  1993 A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine. RSV
21  1993 TNF-alpha and cyclooxygenase metabolites do not modulate C. albicans septic shock with disseminated candidiasis. CFU, HK, TNF-alpha
22  1990 Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization. RSV